| 发明名称 |
Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve |
| 摘要 |
The invention is directed to methods for treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve. The invention is further directed to treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve by administering to a subject suffering from such conditions Amnion-derived Cellular Cytokine Solution (ACCS), including immediate-release, targeted-release, and sustained-release (SR) ACCS compositions (referred to herein as “SR-ACCS” compositions) and/or Amnion-derived Multipotent Progenitor (AMP) cell compositions. Such administration includes intranasal administration of ACCS and/or AMP cells. |
| 申请公布号 |
US9636364(B2) |
申请公布日期 |
2017.05.02 |
| 申请号 |
US201414556300 |
申请日期 |
2014.12.01 |
| 申请人 |
STEMNION, INC. |
发明人 |
Brown Larry R;Sing George L;Wessel Howard C |
| 分类号 |
A61K35/50;A61K38/19;A61K9/00;A61K9/19 |
主分类号 |
A61K35/50 |
| 代理机构 |
|
代理人 |
Palladino Linda O.;Kempler Gail M. |
| 主权项 |
1. A method for treating concussive injuries to the eye in a patient in need thereof comprising administering to the patient a therapeutically effective amount of a composition selected from the group consisting of Amnion-derived Cellular Cytokine Solution (ACCS) and Amnion-derived Multipotent Progenitor (AMP) cells. |
| 地址 |
Pittsburgh PA US |
